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ABSTRACT 
 
Numerous microorganisms colonize the human gastrointestinal tract playing pivotal roles in relation 
to digestion and absorption of dietary components. They biotransform food components and 
produce metabolites, which in combination with food components shape and modulate the host 
immune system and metabolic responses. Reciprocally, the diet modulates the composition and 
functional capacity of the gut microbiota, which subsequently influence host biochemical processes 
establishing a system of mutual interaction and inter-dependency. Macronutrients, fibers, as well as 
polyphenols and prebiotics are strong drivers shaping the composition of the gut microbiota. 
Especially, short-chain fatty acids produced from ingested fibers and tryptophan metabolites are key 
in modulating host immune responses. Since reciprocal interactions between diet, host, and 
microbiota are personal, understanding this complex network of interactions calls for novel use of 
large datasets and the implementation of machine learning algorithms and artificial intelligence. In 
this review, we aim to provide a base for future investigations of how interactions between food 
components and gut microbiota may influence or even determine human health and disease.    
    
Keywords: gut microbiota; macronutrients; polyphenols; prebiotics; health; disease.  
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1. INTRODUCTION 
The complex microbial communities present in the intestinal tract play pivotal roles as 
modulators of metabolic responses, the immune system, and human health (Ventura, O'Toole, de 
Vos, & van Sinderen, 2018). It is widely accepted that many aspects of human health are affected 
by the gut microbiota, although information regarding mechanisms of action is still missing 
(Ventura et al., 2018). In particular, studies addressing causality in relation to observed correlations 
are scarce (Surana & Kasper, 2017). Nevertheless, numerous studies have corroborated the notion 
that the intestinal microbial communities play an important role in energy homeostasis and may 
thus modulate weight loss or gain and obesity-associated disorders (Rosenbaum, Knight, & Leibel, 
2015). The gut microbiota and bacterial metabolites have also been associated with regulation of 
blood pressure (Marques, Mackay, & Kaye, 2018), chronic kidney disease (Sircana et al., 2018) and 
critical factors associated with cardiovascular disease. Additionally, alterations in gut microbial 
composition or function have been associated with age-related health impairment (Clark & Walker, 
2018; O'Toole & Jeffery, 2018), changes in host immune status (Rooks & Garrett, 2016), and thus, 
inflammatory bowel disease, allergy, and asthma (Carding, Verbeke, Vipond, Corfe, & Owen, 
2015). 
Therefore, several studies have focused on how different factors can modulate the 
composition and function of the gut microbiota (Marchesi et al., 2016). Diet is currently considered 
as one of the most important modifiers (Graf et al., 2015). Macronutrients and micronutrients, as 
well as prebiotics, probiotics (Wang et al., 2015), food additives, and other minor components 
including contaminants can modulate the microbiota (Roca-Saavedra et al., 2018). The overall 
balance between the macronutrients protein, carbohydrate and fat is known to influence the 
composition and functional potential of the gut microbiota (reviewed in Madsen, Myrmel, Fjaere, 
Liaset, & Kristiansen, 2017). Due to the compositional nature of a diet, it may therefore be difficult 
to clearly define the individual roles of each dietary component on the gut microbiota. The 
following subdivisions should be regarded in this light. The objective of this article is to review the 
most recent knowledge regarding effects of the main food components, encompassing 
carbohydrates, proteins, lipids, prebiotics, and polyphenols on the gut microbiota, and the health 
benefits on the host of metabolites derived from microbial biotransformation of these food 
components. 
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2. EFFECT OF CARBOHYDRATES ON MICROBIOTA 
Intake of complex carbohydrates, so-called fibers, is associated with beneficial effects in a 
wide range of conditions including obesity, inflammatory bowel disease, and asthma in both rodents 
and humans (Cazarin et al., 2016; Kovatcheva-Datchary et al., 2015; Trompette et al., 2014). While 
simple carbohydrates typically are completely absorbed in the small intestine, a large number of 
complex carbohydrates from the diet is not digested in the upper gastrointestinal tract, owing to 
their resistance towards the enzymatic activities of human digestive enzymes. Consequently, the 
complex, mostly non-starch and resistant starch, dietary polysaccharides pass through the small 
intestine and serve as substrates for the colonic microbiota. These compounds can be fermented by 
several gut bacterial species leading to the generation of metabolites such as short-chain fatty acids 
(SCFAs), CO2, and H2 that shape the intestinal environment (Chassard & Lacroix, 2013).  
The consumption of a plant-based diet, rich in fiber, correlates with an increased abundance 
of the genera Roseburia, Lachnospira and Prevotella as well as increased SCFA production (Figure 
1) (De Filippis et al., 2015). Both changes in gut microbiota composition and metabolite 
abundances by intake of fiber may independently influence disease outcome. However, it is 
important to note that fiber may also impact the host through effects independent of the gut 
microbiota, for example through fecal bulking. Not all fibers are equal in terms of ability to modify 
gut microbiota composition and activity. First, not all types of fibers are converted by the 
microbiota, and only the microbiota accessible carbohydrates (MAC) will elicit the generation of 
the metabolites described above. Secondly, particular fiber types serve as substrates for certain 
bacteria, and some of the produced biotransformed products may be used as substrates for other 
bacteria in the community (Reviewed in Cockburn & Koropatkin, 2016). As most members of the 
gut microbiota are biased towards metabolizing mono- and oligosaccharides, and bacteria differ in 
their carbohydrate processing capabilities, cross-feeding between bacteria is essential for optimal 
digestion of complex polysaccharides (Cockburn & Koropatkin, 2016). In basic terms, cross-
feeding between bacteria will overall lead to the development of individually-based bacterial 
community structures depending on the types of ingested fibers, and thus, a change in the intake of 
fiber types may elicit complex changes in the overall structure and function of the  gut microbiota. 
Gut bacteria vary greatly in the number of polysaccharide degrading enzymes. While some bacteria 
are considered generalists and thus able to metabolize a wide array of carbohydrates, others are 
highly specialized. Many members of the Bacteroidetes phylum including Bacteroides 
thetaiotaomicron and Bacteroides intestinalis are putative generalists (El Kaoutari, Armougom, 
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Gordon, Raoult, & Henrissat, 2013). In contrast, other members of the gut microbiota, for example, 
Prevotella copri and Rosaburia intestinalis are putative specialists (El Kaoutari, Armougom, 
Gordon, Raoult, & Henrissat, 2013). Thus, it is likely that effects of dietary carbohydrates on gut 
microbiota do not influence the different species equally. The fiber-related bacterial community 
dependency was nicely illustrated in a recent study (Reichardt et al., 2018). By incubating human 
feces with fifteen non-digestible carbohydrates it was demonstrated that not only the type of 
substrates offered to the microbiota, but also the interactions between the bacteria in the intestinal 
environment were important for the type of SCFAs being produced. Specifically, Eubacterium 
hallii utilized 1,2-propanediol produced from rhamnose by Blautia spp. (Reichardt et al., 2018). The 
authors suggested that the absence of some keystone species could decrease non-digestible 
carbohydrate fermentation. In addition, it was reported that the initial pH of the environment, by 
affecting the activity of transferases involved in butyrate formation, may control butyrate 
production (Reichardt et al., 2018). Another recent study illustrated how differential chain-length 
preferences in bacteria for capture and transport of xylosyl units facilitate bacterial co-growth on 
abundant dietary fibers such as xylan (Leth et al., 2018). Combined this illustrates the complexity 
related to understanding the role of fiber types in shaping the gut microbiota composition and SCFA 
production.  
While functional fiber-microbiota interactions are still challenging to pinpoint in vivo, the 
extensive use of correlation analyses has shown clear connections between the amount of dietary 
fiber intake, the activity of different bacteria, and the formation of SCFAs in humans. A study by 
Duncan et al., (2007) provides an example of such connections. In this study, 19 healthy obese male 
volunteers received a diet low in carbohydrates/fibers. They observed changes in the gut microbiota 
comprising a decreased abundance of Roseburia spp, Eubacterium rectale and Bifidobacteria, 
concomitant with a decrease in the level of SCFAs in feces, and with the reduction in fiber intake 
correlating with decreased levels of butyrate in feces. 
Changes in fiber intake may further have trans-generational effects regarding the shaping of 
the gut microbiota composition. As an example, Roytio, Mokkala, Vahlberg, & Laitinen (2017) 
observed a positive correlation between fiber intake and the diversity and richness of the microbiota 
in overweight pregnant women. Such changes may persist for generations as Sonnenburg et al. 
(2016) observed that low intake of MAC decreased the diversity of the microbiota, and this 
decrease persisted through four generations of mice, and was not reversible even after increasing 
MAC intake in the offspring. Given the effect of maternal environmental factors on offspring, these 
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data are relevant to understanding the impact of the transition to a Western diet, typically low in 
dietary fiber, in relation to the long-term incidence of a number of non-communicable diseases.  
 
3. EFFECT OF PREBIOTICS ON MICROBIOTA 
Dietary prebiotics are defined as substrates that are selectively utilized by host 
microorganisms conferring a health benefit (Gibson et al., 2017). They typically consist of non-
digestible carbohydrates although the concept of prebiotics has expanded to include a broader array 
of compounds (Gibson et al., 2017). Prebiotics consisting of oligosaccharides are common 
ingredients in nutritional supplements designed for clinical management of disease states, but solid 
documentation proving their benefits to intestinal morphology and function is scarce. Studies have 
emphasized the importance of the relationship between prebiotics and the gut microbiota. One of 
the functional effects of prebiotics has been related to an increase of the abundance of 
Bifidobacterium and Lactobacillus species given their ability to aid digestion, reduce constipation, 
resist infections, prevent traveler’s diarrhea, and ameliorate inflammatory bowel disease (Figure 1) 
(reviewed in Gibson et al., 2010). Other effects have been reported in relation to prebiotics, gut 
microbiota composition, and lactose intolerance. In a randomized trial, Azcarate-Peril et al. (2017) 
tested the impact of highly purified (>95%) galactooligosaccharides (GOS) on the colonic bacteria 
in humans with self-reported dairy intolerance. In response to GOS, the authors found an increase in 
the relative abundance of Bifidobacterium, Faecalibacterium, and Lactobacillus (Figure 1). 
Introduction of dairy products into the diet increased the abundance of Roseburia species 36 to 66 
days after the intervention, which correlated with improvements in lactose tolerance. These results 
suggest that lactose-metabolizing bacteria interact with GOS to improve tolerance to dairy products. 
Of note, prebiotics may result in localized activity in sub-compartments of the colon. Using a 
Simulator of the Human Intestinal Microbial Ecosystem, Daguet et al. (2016) showed that 
fructooligosaccharides (FOS) and arabinogalactan increased SCFA synthesis in different areas of 
the colon (proximal colon for FOS, and distal colon for arabinogalactan fermentation).  
The gut barrier refers to the intestinal cells and mucus layer that under normal conditions 
constitute an impenetrable barrier against host exposure to large luminal molecules. A decrease in 
gut barrier function may lead to intestinal inflammation and the influx of larger luminal molecules 
such as lipopolysaccharides associated with detrimental effects on the host (reviewed in Ramanan 
& Cadwell, 2016; Winer, Luck, Tsai, & Winer, 2016). By inoculating co-cultures of enterocytes, 
such as Caco-2 cells, and monocytes (THP1) with filtered simulator suspensions, Daguet et al. 
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(2016) showed that compartment-specific metabolites might lead to differential effects in relation to 
gut barrier function.  
There is also evidence that addition to infant formula of FOS and GOS, which are different 
from oligosaccharides present in human milk, results in softening of the fecal bolus, decreased stool 
pH, increased luminal osmotic water binding capacity and fecal SCFA level as compared to non-
prebiotics added formula (reviewed in Vandenplas, Zakharova, & Dmitrieva, 2015). Prebiotic 
supplementation may also hold potentials in older children. In a randomized trial, the effects of 
GOS ingestion were tested in pediatric patients (4-16 years of age) with chronic constipation. This 
study demonstrated that administration of 1.7 gram of GOS per day increased bowel movement 
frequency, relieved straining during defecation, and decreased stool consistency in comparison with 
the placebo group receiving maltodextrin (Beleli, Antonio, dos Santos, Pastore, & Lomazi, 2015).  
It is important to note that prebiotics may not only exert their effects by modifying abundance 
or activity of microbes. A novel mechanism based on specific and direct prebiotic interactions using 
inulin and short-chain FOS demonstrated improved ability to maintain epithelial barrier function 
and to protect from injury caused by the non-invasive pathogen enterohemorrhagic E. coli O157:H7 
(EHEC) despite the absence of other microbes (Wu et al., 2017). GOS may also inhibit adherence 
of E. coli to enterocytes (Shoaf, Mulvey, Armstrong, & Hutkins, 2006). These results suggest that 
prebiotics may improve gut barrier function, and may be relevant for specific consumer groups 
during certain phases of life.  
 
4. EFFECT OF PROTEINS ON MICROBIOTA 
Studies focusing on protein intake have pinpointed how consumption of a Western diet rich in 
meat, which is typically high in animal-based protein, is reflected in the composition and functional 
potential of gut bacterial communities in humans (Wu et al., 2011). The general influence of animal 
protein intake on the gut microbiota composition is also demonstrated by the difference in 
microbiota compositions of carnivores and herbivores (Muegge et al., 2011). Intake of animal-based 
protein has been associated with an increased risk for development of atherosclerosis. This is 
envisaged to be dependent on transformation of L-carnitine and phosphatidylcholine, present in red 
meats and egg (Koeth et al., 2013; Tang et al., 2013). These compounds are converted into 
trimethylamine by the gut microbiota and subsequently transformed into trimethylamine oxide 
(TMAO) in the liver, leading to elevated levels of TMAO in circulation (Koeth et al., 2013; Tang et 
al., 2013). High level of TMAO in the circulation was also recently linked to obesity development 
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(Dumas et al., 2017). While the data linking TMAO to atherosclerosis seem convincing, the fact 
that intake of fish, known to protect against cardiovascular diseases, also leads to elevated levels of 
TMAO in circulation has raised skepticism concerning the link between TMAO and cardiovascular 
disease (Cho et al., 2017; Landfald, Valeur, Berstad, & Raa, 2017). However, in a recent study 
focusing of the gut microbiota of 218 individuals with atherosclerosis, it was found that the 
potential for TMA production in bacteria was a common denominator (Jie et al., 2017), hence 
pointing to continuous supply of TMA from the bacterial pool as a possible disease contributor 
(Figure 1). 
In contrast to intake of animal protein, intake of plant protein appears to induce positive 
effects on metabolism and intestinal homeostasis. Thus, a large prospective cohort study showed 
that intake of plant protein was associated with a moderately decreased risk of type 2 diabetes 
(Malik, Li, Tobias, Pan, & Hu, 2016). A meta-analysis including 13 randomized controlled trials 
also showed improved glycemic control, as measured by lowered HbA1c, by replacing animal with 
plant protein (Viguiliouk et al., 2015). Rodent studies have corroborated results in humans. Mice 
fed a high-fat/high-protein diet based on soy gained less weight than mice fed diets based on cod, 
beef, chicken and pork, but still, mice fed the soy-based diet gained more weight than mice fed a 
diet based on casein (Liisberg et al., 2016). By contrast, rats fed a high-fat diet based on soy protein 
gained less weight and displayed lower body fat content compared to rats fed a high-fat diet based 
on casein (Torre-Villalvazo, Tovar, Ramos-Barragan, Cerbon-Cervantes, & Torres, 2008). These 
results could involve changes in the gut microbiota as rats fed soy protein showed lower levels of 
Lactobacillus compared to rats fed meat proteins (Zhu et al., 2015). The results revealed a tighter 
microbiota clustering of rats fed the non-meat proteins casein and soy, again indicating 
compositional and functional differences between rats fed diets based on meat proteins and non-
meat proteins (Zhu et al., 2015). A follow-up study showed that young rats fed a diet with proteins 
from chicken (17.7%) for 14 days exhibited an increase in the relative abundance of the genus 
Lactobacillus, whereas the opposite pattern was observed in middle-aged rats (Zhu et al., 2017).  
Mouse studies have shown that proteins from seafood as constituents of a Western diet are 
less obesogenic than proteins from terrestrial animals. This difference in obesity development was 
associated with changes in the relative abundance of Bacteroidales and Clostridiales (Figure 1), 
accompanied with changes in the abundance of genes involved in metabolism of aromatic amino 
acids in the microbiomes of mice fed the seafood-based Western diet (Holm et al., 2016). In 
comparison to terrestrial protein sources, seafood protein contains high levels of taurine (Spitze, 
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Wong, Rogers, & Fascetti, 2003). Addition of taurine to the diet or drinking water has been 
demonstrated to prevent diet-induced obesity and steatosis in rodents (Chang et al., 2011; Nakaya et 
al., 2000; Nardelli et al., 2011). In mice, taurine supplementation reduced the abundance of 
Proteobacteria, especially Helicobacter and resulted in increased SCFA content in feces (Yu, Guo, 
Shen, & Shan, 2016), changes that would be expected to improve gut health. 
Protein sources from milk (casein and whey protein) have also been reported to convey anti-
obesogenic effects in mouse models on high-fat diets (Liisberg et al., 2016; Lillefosse et al., 2014; 
McAllan, Speakman, Cryan, & Nilaweera, 2015; Tranberg, Madsen, Hansen, & Hellgren, 2015). 
The actions of casein and whey-based feed have been related to the high content of the branched-
chain amino acids (BCAAs) valine, leucine, and isoleucine. Interestingly, supplementation with 
dietary BCAAs in mice was reported to delay age-dependent changes in the gut microbiota (Yang et 
al., 2016) and to increase the abundance of Akkermansia and Bifidobacterium in the gut. High levels 
of A. muciniphilia (Everard et al., 2013; Shin et al., 2014) and some strains of Bifidobacteria (An et 
al., 2011; Z. Li, Jin, Oh, & Ji, 2016; Wang et al., 2015) have been reported to protect against diet-
induced obesity. Intake of a whey protein isolate has also been reported to specifically increase the 
abundance of Lactobacillaceae/Lactobacillus (Figure 1) and decrease the abundance of 
Clostridiaceae/Clostridium (McAllan et al., 2015), and in comparison to casein, whey protein 
intake was reported to increase the levels of Lactobacilli and Bifidobacteria in a rat model of colitis 
(Sprong, Schonewille, & van der Meer, 2010). Several species of Lactobacilli have been reported to 
reduce adiposity in mice and be associated with weight-loss in humans (Park et al., 2013; Yoo et al., 
2013; Isokpehi, Simmons, Johnson, & Payton, 2017) suggesting that protein-associated changes in 
the gut microbiota might be causally linked with improved metabolic function.  However, it remains 
to be established whether such changes in the composition of the gut microbiota are causally related 
to the anti-obesogenic actions of specific proteins such as milk and plant proteins.  
 
5. EFFECT OF LIPIDS ON THE MICROBIOTA 
The gut microbiota plays a pivotal role in relation to many chronic disorders that are 
influenced by the type and level of dietary fat intake. One example is obesity, which has been 
associated with taxonomical changes in the gut microbiota, and where the changes may likely 
reflect differences in dietary fat levels or lipid types rather than obesity (Caesar, Tremaroli, 
Kovatcheva-Datchary, Cani, & Backhed, 2015; Xiao et al., 2017; Yu et al., 2014). The amount of 
dietary fat in modern Western diets is comparable to a Paleolithic intake, but it is likely that the 
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types of ingested lipids have undergone marked shifts during human evolution (Eaton, Eaton, 
Konner, & Shostak, 1996). Changes in the type of dietary lipids may also play a role in eliciting the 
changes in microbiota composition seen in Westernized as compared to indigenous human cultures 
(De Filippo et al., 2010; Rampelli et al., 2015).  
While it is well documented that differences in carbohydrate and protein consumption may 
drive changes in the composition of the gut microbiota (Holmes et al., 2017), the role of lipids is 
less well established. However, some lipids seem to elicit significant changes in the gut microbiota 
composition. Studies of conventionally raised and germ-free mice fed diets with lipids of different 
fatty acid composition show that the interaction between the dietary fat source and the gut 
microbiota impacts on weight gain, adipose tissue inflammation, and colitis (Caesar, Tremaroli, 
Kovatcheva-Datchary, Cani, & Backhed, 2015; Devkota et al., 2012). Thus, transfer of microbiota 
from mice fed fish oil- versus lard-based diets into germ-free mice lowered weight gain and lard-
induced inflammation (Caesar et al., 2015; Cazarin et al., 2015). Similarly, colitis only occurred in 
germ-free mice mono-colonized with Bilophila wadsworthia if the mice were fed a milk-fat based 
diet, whereas a safflower oil-based diet did not elicit a response (Devkota et al., 2012). In order to 
understand such interactions, it is imperative to understand how different lipids interact with our gut 
microbiota.  
Few dietary intervention studies have focused exclusively on modulating the type of dietary 
fat source. Still, the dietary lipid origin has been shown to impact both on the composition and 
diversity of the cecal and colonic microbiota in rodents (Caesar et al., 2015; Huang et al., 2013; Li 
et al., 2017; Patterson et al., 2014; Robertson et al., 2017), driving associations in humans between 
certain bacterial taxa and different dietary fats (Wu et al., 2011). In the few studies conducted in 
rodents, the effect of fat source on bacterial taxa differs somewhat between studies. One study in 
mice fed a lard-containing diet reported an increase in the abundance of Bacteroides, Turicibactor, 
and Bilophila, while mice consuming a fish oil-based diet were enriched for Bifidobacterium, 
Adlercreutzia, Lactobacillus, Streptococcus, and Akkermansia muciniphila (Caesar et al., 2015). In 
contrast, another study on rats reported an increase in Akkermansia in response to intake of a lard-
containing diet, while intake of a fish oil-containing diet was associated with a higher abundance of 
Desulfovibrio, Bilophila, Desulfovibrio, and Helicobacter (Li et al., 2017). The different results 
may relate to differences in study designs, e.g., different rodent species, sample handling, 16S 
rRNA profiling, dietary fat amount and/or fat origin.  
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Although lipids may modulate the gut microbiota, the identity of the factors in dietary fat 
important for this regulation has not been fully established. For example, it is not clear to which 
extent fatty acid composition, viscosity or n-6/n-3 polyunsaturated fatty acid ratio impact on the gut 
microbiota. The gut microbiota regulates bile acid synthesis and modulates conjugation of 
secondary bile acids. Visa versa, bile acids modify the gut microbiota, for example by promoting 
the growth of bacteria using bile acids as a substrate or through antimicrobial effects (reviewed in 
Wahlstrom, Sayin, Marschall, & Backhed, 2016). Due to the bi-directional relationship between the 
gut microbiota and bile acid metabolism, it is not clear to what extent dietary lipids impact on 
microbial composition directly, e.g., via acting as a substrate for bacterial metabolism, and/or via 
secondary metabolites such as changes in bile acid composition. Experiments interfering with bile 
acid synthesis or metabolism may, in combination with intake of various dietary lipids, shed light 
on direct effects of fatty acid on the gut microbiota. Another approach is to use systems such as an 
artificial gut.     
 Differences in intake of dietary fatty acids also affect temporal changes in the gut microbiota. 
A high-fat/high-sucrose diet may rapidly alter the composition of the gut microbiota in rodents 
(Collins et al., 2016). However, in our hands, cecal and colonic microbiota in mice did not change 
significantly during five weeks on a safflower based high-fat/high-sucrose diet (Danneskiold-
Samsoe et al., 2017). One explanation for this could be that only very few percentages of the 
ingested lipids reach the gut bacteria in the colon (Booth, Alldis, & Read, 1961), due to their main 
absorption in the ileum part of the small intestine.  
Contrasting the knowledge of complex carbohydrates, it is still unclear if and how lipids 
change the microbiota in the large intestine in humans. Further studies are needed to fully elucidate 
how different dietary lipids impact on the composition and functional capacity of the gut 
microbiota. 
 
6. EFFECT OF POLYPHENOLS ON MICROBIOTA 
Phenolic compounds are phytochemicals found in a huge variety of fruits and vegetables 
being secondary metabolites in plants. This class of compounds is characterized by the presence of 
various hydroxyl groups in aromatic rings and are divided into two main categories: flavonoids and 
non-flavonoids (Santhakumar; Battino;  Alvarez-Suarez, 2018). Interest in phenolic compounds is 
related to their health beneficial effects which have been associated with anti-oxidant, anti-
inflammatory, cardioprotective, cancer preventive, and neuroprotective properties (Figure 1) 
(Selma; Espín; Tomás-Barberán, 2009). 
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The intestinal microbiota is capable of metabolizing phenolic compounds making them 
potentially more biologically active than the primary compounds and more easily absorbed by the 
body (Selma; Espín; Tomás-Barberán, 2009). One such example was recently described by 
Theilmann et al., illustrating the capacity of Lactobacillus acidophilus for deglucosylation of 
dietary plant glycosides making the produced aglycones of the plant glycosides available for 
modification by other bacterial taxa or for direct use by the host. Polyphenols may also modulate 
the gut microbiota in a process termed the prebiotic-like effect (Tomás-Barberán; Selma; Espín, 
2016). The classical prebiotic-like effect of polyphenols has been investigated in in vitro assays 
using human microbiota, and in preclinical and clinical studies with polyphenol-rich food. 
Sun et al. (2018), evaluated the in vitro effect of green tea, oolong tea, and black tea on 
samples of the intestinal microbiota and concluded that the tea polyphenols significantly increased 
the abundance of Bifidobacterium, Lactobacillus spp. and Enterococcus spp. (Figure 1), and also 
enhanced SCFA production, while restraining the proliferation of the Bacteroides, Prevotella and 
Clostridium histolyticum groups. Moreover, Larrosa et al. (2009) studied the effect of resveratrol on 
the colon microbiota in a rat model of DSS-induced colitis and observed an increase in Lactobacilli 
and Bifidobacteria with a concurrent decrease in the abundance of E. coli and Enterobacteria.  
Polyphenols can modulate the gut microbiota by promoting the growth of specific gut 
microbial species including Akkermansia spp., Faecalibacterium spp. and Roseburia spp. (Figure 1) 
that may provide beneficial health effects to the host (Reviewed in Espín et al., 2017; Tomás-
Barberán et al., 2016). Akkermansia is a mucin-degrading bacterium that resides in the mucus layer, 
and its abundance is inversely correlated with body weight and with an improved metabolic profile 
(Everard et al., 2013). Faecalibacterium spp. and Roseburia spp. are among the most abundant 
butyrate-producing gut bacteria. Corroborating these results, Moreno-Indias et al. (2016) studied the 
effect of red wine polyphenols in obese patients with metabolic syndrome and concluded that 
polyphenols increased the number of butyrate-producing bacteria.  
Due to the vast number of polyphenolic compounds, the high number of derived 
bioconversion products and their interaction with the gut microbiota, it has in general been difficult 
convincingly to link beneficial health effects to specific polyphenolic compounds. This situation has 
now been greatly improved by the development of Phenol Explorer Database Release 3.0 (Rothwell 
et al., 2013), which is an assembly of a large array of metabolite data obtained from analyses of 
urine and plasma samples collected after intake of polyphenolic compounds and coupled to health 
data. Broadly speaking, the many plant-derived polyphenolic products make up a vast variety of 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 
bioactive compounds reported to elicit positive effects with regard to anti-microbial, anti-oxidant, 
anti-inflammatory, anti-diabetic, and anti-cancer activities based on studies in ex vivo cell systems 
or results obtained after intake of phenolic-rich compounds (Scalbert, Manach, Morand, Remesy, & 
Jimenez, 2005). 
 
7. FOOD-DERIVED MICROBIAL METABOLITES AFFECTING HEALTH AND 
DISEASE 
As illustrated above, several of the food-derived microbial degradation products/metabolites 
have been demonstrated to hold health beneficial properties via their effects on local and systemic 
inflammatory paths involved in different disease processes. Most studied effects relate to the 
SCFAs derived from gut bacterial fermentation of certain fibers, the tryptophan metabolites, 
resulting mainly from bacterial conversion of the dietary amino acid tryptophan, and the 
polyphenolic degradation products derived from bacterial metabolism of dietary phenolic 
compounds. Overall, these products are associated with favorable health-related phenotypes via 
modification of pro-inflammatory cues driving lifestyle-related, inflammation-mediated diseases, 
which will be addressed in more detail below.  
The fiber-derived fermentation products including the SCFAs butyrate, propionate and acetate 
contribute to a variety of positive health effects both locally in the intestine and systemically. For 
example, in animal models of inflammatory bowel disease, where reduced levels of SCFAs in the 
feces associate with disease severity (Cazarin et al., 2015), and in humans, where lack of bacteria 
with potential for SCFA production is a signature of Crohn’s disease patients (He et al., 2017). 
Butyrate has been shown to hold widely acting effects by inducing mucin synthesis, decreasing 
bacterial transport across the epithelium, and improving gut integrity by increasing tight junction 
assembly (Peng, Li, Green, Holzman, & Lin, 2009). In general, SCFAs have been shown to act as 
histone deacetylase inhibitors and ligands for G protein-coupled receptor 41 (GPR41), G protein-
coupled receptor 43 (GPR43), (all SCFAs) and G protein- coupled receptor 109A (butyrate) locally 
in the gut resulting in suppression of pro-inflammatory cytokine secretion (Arpaia et al., 2013; 
Furusawa et al., 2013). Butyrate and propionate are also able to influence differentiation of naïve T 
cells into Tregs, the latter playing a vital role in controlling intestinal homeostasis (Arpaia et al., 
2013; Smith et al., 2013).  
Moreover, via its interaction with GPR109A, butyrate has been shown to mediate secretion of 
IL-18 via intestinal epithelial cells (Singh et al., 2014), which is reported to be involved in 
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suppression of colonic inflammation (Elinav et al., 2011; Salcedo et al., 2010). It is important to 
note that GPR109A is also a receptor for niacin, wherefore dietary niacin may be able to mediate 
some of the GPR109A-related effects (Singh et al., 2014). GPR109A additionally triggers secretion 
of immunosuppressive IL-10 and class 1A aldehyde dehydrogenase (Aldh1A) from dendritic cells 
and macrophages of importance for intestinal homeostasis. Neutrophils, which are vital for removal 
of extracellular pathogenic microorganisms, also act under the influence of SCFAs, where GPR43 
is reported to be involved in regulating neutrophilic activity (Sina et al., 2009). Moreover, 
propionate may play a role in relation to iron deficiency, which is a serious health problem that 
eventually may lead to reduced cognitive development, growth impairment, and inflammatory 
states. In this regard, propionate seems to enhance iron absorption in the proximal colon (Bougle et 
al., 2002).  
The secretion of glucagon-like peptide-1 (GLP-1), which is an incretin hormone responsible 
for stimulating insulin release, has been linked with the levels of SCFAs in the gut (Lin et al., 2012; 
Yadav, Lee, Lloyd, Walter, & Rane, 2013). Butyrate seems to most potently increase GLP-1 
secretion, followed by propionate and lastly acetate. Several studies have shown that if GPR41 and 
GPR43 are both lacking, then GLP-1 secretion is reduced (Tolhurst et al., 2012; Yadav et al., 2013). 
Butyrate may moreover improve insulin sensitivity. In this regard, Gao et al. (2009) showed 
improved insulin sensitivity in mice fed butyrate at 5% wt/wt for 16 weeks as part of a high-fat diet. 
A recent study by Zhao et al. (2018) has likewise demonstrated positive effects of expanding certain 
gut bacteria by a dietary fiber intervention in type 2 diabetic individuals, linked with GLP-1 
secretion enhancement and HbA1c improvement. SCFAs also appear to play a role in relation to 
type 1 diabetes, as type 1 non-obese diabetic (NOD) mice supplemented with acetate and butyrate 
exhibited reduced incidence of diabetes by boosting local Treg function, suppressing numbers of 
autoreactive T cells, and by enhancing gut integrity (Marino et al., 2017).  
SCFAs are also reported to mediate effects in organs distant from the gut. One seminal study 
by Trompette et al. (2014) illustrated how diet-induced changes of SCFA production in gut 
microbiota influence the lung immune system of relevance in asthma. Four groups of mice were fed 
with a readily fermentable fiber diet (pectin-rich), a poorly fermentable fiber diet (cellulose), a 
control diet (4% fiber) or a low-fiber diet (<3% fiber). Intake of the low fiber diet resulted in an 
increase in IL-4, IL-5, IL-13, IL-17A, goblet cell hyperplasia, and increased mucus production in 
lung tissue, as well as in circulating total levels of IgE antibodies, all being phenotypic markers in 
asthma. Mice fed the pectin-rich diet showed the opposite results (Trompette et al., 2014). 
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Trompette et al. (2014) further showed that mice treated with propionate increased the numbers of 
dendritic cells in the bone marrow, and these dendritic cells exhibited an impaired ability to activate 
Th2 effector cells in the lung, thus alleviating induced asthma symptoms.  
 
Bacterial-derived tryptophan metabolites are also potent modifiers of host health. The amino 
acid tryptophan released from digestion of protein is converted to different tryptophan metabolites 
by the microbiota, resulting in an array of different tryptophan metabolites, such as indole, indole-3-
acetate, indole-3-aldehyde, and tryptamine with different ligand properties. Tryptophan metabolites 
have been shown to mediate their function via binding to the aryl hydrocarbon receptor (AhR) 
present in certain immune cell subsets, including all innate lymphoid cell (ILC) subtypes, 
monocytes, macrophages, and dendritic cells (www.immgen.org). The AhR is involved in 
regulation of insulin responsiveness, energy expenditure and specialization of a subtype of ILCs 
called ILC22, which plays a part in promoting gut barrier integrity (Figure 1) (Lee et al., 2011). 
Lack of tryptophan metabolites has been linked to inflammatory bowel disease (Lamas et al., 2016; 
Monteleone et al., 2011), weight changes (Lu et al., 2015; Monteleone et al., 2011), and insulin 
resistance (Lu et al., 2015; Wang et al., 2011). Activation of the AhR is known to regulate genes 
containing upstream XRE boxes, and to stimulate degradation of specific regulatory proteins via 
ubiquitination (Nguyen, Hanieh, Nakahama, & Kishimoto, 2013). This results in a wide span of 
regulatory effects and powerful responses, in particular to regulation of genes related to cell 
specialization (Lamas et al., 2016; Monteleone et al., 2011; Veldhoen et al., 2008), insulin 
sensitivity (Lu et al., 2015; Roh et al., 2015; C. Wang et al., 2011), autoimmune responses 
(Uyttenhove & Van Snick, 2006), and energy consumption (Lu et al., 2015; Monteleone et al., 
2011). The amount and composition of microbial-derived tryptophan metabolites interacting with 
AhR might be of great importance in the causation chain from diet to health.  
While it is well-documented that gut bacteria-derived metabolites from the amino acid 
tryptophan contribute to positive health effects, it seems that switching of gut bacteria towards 
production of the BCAAs may mediate negative health effects. Recent focus has been directed 
towards the possible adverse metabolic effects mediated via production of BCAA by specific gut 
bacteria, such as Prevotella copri and Bacteroides vulgatus, during certain high fat and low fiber 
conditions (Pedersen et al., 2016). Contrarily, BCAAs seem not to be produced by bacteria during 
high dietary fiber intake (Kovatcheva-Datchary et al., 2015), hence suggesting a role of the diet in 
bacterial BCAA production. The role of BCAAs in regulation of metabolism is complex and far 
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from elucidated with several studies showing that increased diet-based intake of BCAAs protects 
against obesity and insulin resistance (Freudenberg, Petzke, & Klaus, 2012, 2013; Newgard et al., 
2009), whereas increased potential for BCAA synthesis in gut bacteria has been associated with 
insulin resistance (Pedersen et al., 2016). The adverse effects of BCAAs may be promoted when 
BCAAs are not used as constituents for the build-up of muscle proteins (non-exercising conditions), 
resulting in increased circulating levels that may interfere with insulin signaling. The possible 
continuous supply of BCAA to metabolic organs due to microbial production of BCAA is thus 
speculated to play a role in driving an insulin-resistant phenotype in inactive individuals with low 
fiber/ high fat dietary habits (Pedersen et al., 2016). 
 
Concerning the polyphenolic compounds, the reciprocal interactions between gut microbiota 
and dietary phenolic compounds influence the bioavailability of the compounds and their effects on 
human health. As stated earlier, phenolic compounds that are not absorbed in the small intestine, 
fuel growth of colonic gut bacteria that in turn modify the bioavailability of the phenolic 
compounds (van Duynhoven et al., 2011). The bioavailability and health effects of polyphenols 
largely depend on their biotransformation by certain gut bacteria via specific microbial esterase, 
glucosidase, demethylation, dehydroxylation and decarboxylation activities (Possemiers, Bolca, 
Verstraete, & Heyerick, 2011; Theilmann et al., 2017). Further interaction with the host metabolic 
system occurs via additional phenolic biotransformations, giving rise to hydroxylation of aromatic 
rings, O-methylation, O-demethylation, and conjugation of hydroxy groups to produce glucuronides 
and sulfates based polyphenolic products.  
The anti-oxidant response by some polyphenolic compounds, especially flavonoids, seems to 
be mediated via activation of the transcription factor Nuclear factor (erythroid-derived 2)-like 2 
(Nrf2), which is a regulator of various genes harboring the anti-oxidant response element (ARE) 
(Kumar, Kim, More, Kim, & Choi, 2014). This effect may be partly mediated via interaction with a 
cytosolic form of the AhR (Miao, Hu, Scrivens, & Batist, 2005). Different phenolic compounds, 
especially flavonoids and their metabolites, have been shown to agonistically regulate peroxisome 
proliferator-activated receptor gamma (PPARγ) activation to exert effects on inflammatory 
transcription factors, leading to suppression of inflammation and modification of phenotypes related 
to metabolic diseases (Wang et al., 2014). 
Many of the above-mentioned effects are based on cell culture studies with 
supraphysiological concentrations or studies in animal models. As also stated above, the field has 
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struggled to identify effects of polyphenols in humans. However, a recent meta-analysis based on 
ten human intervention studies reported that different polyphenol-based interventions in humans 
were found to significantly reduce diastolic blood pressure and triglyceride levels (Marx et al., 
2017), while inconclusive effects on systemic pro-inflammatory markers (CRP and IL-6) as well as 
oxidative stress markers, except for myeloperoxidase, were found. Based on this combined analysis, 
Marx and colleagues reported that there was little consistency in outcomes between human studies 
that measured the same outcome and/or used the same intervention (e.g., blood pressure), 
exemplifying the challenge in reproducing effects. Therefore, future studies are required to expand 
the currently limited evidence base on polyphenolic derived health effects in humans. A further 
consideration for future research is also to address the poor bioavailability of specific polyphenols, 
and the inter-individual differences in the gut microbiota, as individual differences in the gut 
microbiota may have a significant impact on the bioconversion of certain polyphenols (Manach et 
al., 2017). Addressing effects of dietary polyphenolic in human interventions may thereby require a 
more person-centric view. 
 
8. CONCLUDING REMARKS 
It is now generally accepted that health benefits from intake of plant-derived foods to a large 
extent are linked to changes in gut microbiota composition and production of bacterially-derived 
metabolites. At present, most focus has been directed towards SCFAs, tryptophan metabolites and 
polyphenolic compounds owing to their various positive effects on immune and metabolic cues of 
relevance in life-style associated diseases. However, due to limited insight into how to modify the 
gut microbiota composition and metabolic capacity by specific diets, we have a yet unexploited 
potential regarding the role of other metabolites. We also lack knowledge of the role of individual 
microorganisms, as well as communities, in relation to uptake and bioconversion of specific dietary 
compounds. It is therefore highly needed that we establish methods to study the role and metabolic 
capacity of single species and complex communities. This includes an understanding of  interactive 
microbial networks in order to increase our knowledge on how to build robust health-promoting 
microbial communities that will adapt positively to personal dietary habits. Given the complexity of 
the vast number of mutual interactions between diet, microbiota, metabolic responses and the 
immune system, the next level of understanding depends on access to big comprehensive data sets, 
the development and implementation of machine learning algorithms, and the use of artificial 
intelligence-based approaches. Information from such comprehensive analyses would be a keystone 
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in developing future approaches for prevention of lifestyle-associated diseases via personalized 
nutrition strategies.  
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Figure 1. Overview of interplay between food components, gut microbiota, metabolites and 
host health. Dietary nutrients are associated with changes in gut microbiota composition and 
activity. Bacterial activity results in the generation of secondary metabolites which again interact 
with gut microbiota and modulate host responses. Genera whose abundance (second column from 
the left) is modulated by selected dietary nutrients (first column from the left). Arrows indicate 
interaction between gut microbiota and metabolites. SCFA: short-chain fatty acid, branched-chain 
fatty acids (BCAA), Ahr: Aryl: aryl hydrocarbon receptor TMAO: trimethylamine oxide. 
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Highlights 
 An overview of how different food components drive changes in the gut microbiota 
 Description of the reciprocal interactions between diet, gut microbiota and host 
 Review of how food components may influence and determine human health 
 Future directions to improve understanding of complex networks between diet, gut microbiota and 
health outcomes 
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